Dr Michelle Kylie Wilson

Selected publications and creative works (Research Outputs)

  • Wilson, M. K., Karakasis, K., & Oza, A. M. (2015). Discrepancies in drug approvals: A global dilemma. Cancer, 121 (18), 3360-3361. 10.1002/cncr.29484
  • Diaz-Padilla, I., Wilson, M. K., Clarke, B. A., Hirte, H. W., Welch, S. A., Mackay, H. J., ... Fleming, G. F. (2015). A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia. Gynecologic oncology, 137 (2), 216-222. 10.1016/j.ygyno.2015.03.005
  • Castonguay, V., Wilson, M. K., Diaz-Padilla, I., Wang, L., & Oza, A. M. (2015). Estimation of expectedness: predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer. Cancer, 121 (3), 413-422. 10.1002/cncr.29030
  • Wilson, M. K., Collyar, D., Chingos, D. T., Friedlander, M., Ho, T. W., Karakasis, K., ... Tannock, I. F. (2015). Outcomes and endpoints in cancer trials: bridging the divide. The Lancet. Oncology, 16 (1), e43-e52. 10.1016/s1470-2045(14)70380-8
  • Wilson, M. K., Karakasis, K., & Oza, A. M. (2015). Outcomes and endpoints in trials of cancer treatment: the past, present, and future. The Lancet. Oncology, 16 (1), e32-e42. 10.1016/s1470-2045(14)70375-4
  • Wilson, M. K., Fong, P., Mesnage, S., Chrystal, K., Shelling, A., Payne, K., ... Rouzbahman, M. (2015). Stage i granulosa cell tumours: A management conundrum? Results of long-term follow up. Gynecologic Oncology, 138 (2), 285-291. 10.1016/j.ygyno.2015.05.011
    Other University of Auckland co-authors: Andrew Shelling
  • Lheureux, S., Wilson, M. K., O'Malley M, Sinaei, M., & Oza, A. M. (2014). Non-target progression--the fine line between objectivity and subjectivity. European journal of cancer (Oxford, England : 1990), 50 (18), 3271-3272. 10.1016/j.ejca.2014.08.021